Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Jason Hurt, Founder & CEO of Theragnostic Insights
In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies - pioneering approaches that are shaping the future of cancer treatment.
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
